Jupiter Life Line Hospitals Adjusts Evaluation Score Amid Stable Financial Metrics
Jupiter Life Line Hospitals has recently adjusted its evaluation score, reflecting changes in the stock's technical landscape. The company maintains strong management efficiency with a 20.63% return on capital employed and a low debt-to-equity ratio. Institutional holdings are at 25.67%, indicating investor confidence.
Jupiter Life Line Hospitals, a midcap player in the hospital and healthcare services industry, has recently undergone an adjustment in its evaluation score. This revision reflects a shift in the technical landscape surrounding the stock, moving from a mildly bearish outlook to a sideways trend. Key financial metrics indicate that the company has maintained a high level of management efficiency, evidenced by a return on capital employed (ROCE) of 20.63%. Additionally, the company's debt-to-equity ratio remains low, suggesting a stable financial structure. Institutional holdings stand at 25.67%, indicating a significant level of confidence from larger investors who typically possess more resources for fundamental analysis.
In terms of performance, Jupiter Life Line Hospitals has generated a return of 14.84% over the past year, outperforming the broader market, which recorded a return of 1.74%. Despite a flat financial performance in the latest quarter, with a profit after tax of Rs 44.86 crore reflecting a decline of 6.5% compared to the previous quarter's average, the stock continues to trade at a discount relative to its peers' historical valuations.
For more insights, Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
